EKO International Corp. (EKNL) Stock
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About EKO International Corp.
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
EKO International Corp. (EKNL) stock trades at $0.00 with a market capitalization of $6337. The stock is valued at price-to-book of 0.00, price-to-sales of 0.00.
On profitability, EKO International Corp. generates a return on equity (ROE) of 33.33% (not meaningful, as shareholders' equity is negative), return on capital employed of 26.75%.
Official website: www.ekointl.com
Related Industrials Stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.